Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology ; day:2 ; month:7 ; year:2024 ; pages:1-11
Therapeutic innovation & regulatory science ; (2.7.2024), 1-11
- Creator
-
Yaegashi, Hiroko
Hayashi, Yukikazu
Takeda, Makoto
Chiu, Shih-Wei
Nakayama, Haruhiko
Ito, Hiroyuki
Takano, Atsushi
Tsuboi, Masahiro
Teramoto, Koji
Suzuki, Hiroyuki
Kato, Tatsuya
Yasui, Hiroshi
Nagamura, Fumitaka
Daigo, Yataro
Yamaguchi, Takuhiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s43441-024-00671-0
- URN
-
urn:nbn:de:101:1-2409202108128.462595731782
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yaegashi, Hiroko
- Hayashi, Yukikazu
- Takeda, Makoto
- Chiu, Shih-Wei
- Nakayama, Haruhiko
- Ito, Hiroyuki
- Takano, Atsushi
- Tsuboi, Masahiro
- Teramoto, Koji
- Suzuki, Hiroyuki
- Kato, Tatsuya
- Yasui, Hiroshi
- Nagamura, Fumitaka
- Daigo, Yataro
- Yamaguchi, Takuhiro
- SpringerLink (Online service)
Other Objects (12)
Quality assurance of investigator initiated clinical trials in oncology
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
The development and challenges of Investigator-Initiated Trials (IITs) in China
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Investigator led trials: challenges and opportunities
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Die Bereitstellung von Daten aus klinischen Prüfungen : Auswirkungen der EU-Clinical Trials Verordnung und des EU-Data Governance Act auf Investigator Initiated Trials (IITs)
Quality assurance of investigator initiated clinical trials in oncology
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
The development and challenges of Investigator-Initiated Trials (IITs) in China
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Investigator led trials: challenges and opportunities
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Die Bereitstellung von Daten aus klinischen Prüfungen : Auswirkungen der EU-Clinical Trials Verordnung und des EU-Data Governance Act auf Investigator Initiated Trials (IITs)
Quality assurance of investigator initiated clinical trials in oncology
Guide for investigator initiated trials
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
The development and challenges of Investigator-Initiated Trials (IITs) in China
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Investigator led trials: challenges and opportunities
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Funding multinational investigator-initiated clinical studies in Europe: why and how?